Mental Retardation Clinical Trial
Official title:
Efficacy of a Health Intervention for People With Intellectual Disabilities
Relatively few health promotion and disease prevention programs have included or targeted
people with disabilities, and even fewer have focused on individuals with intellectual
disabilities.
The long-term objectives of the Healthy Lifestyles for People with Intellectual Disabilities
Study (HLID) are to increase the health of persons with intellectual disabilities by
establishing the efficacy of a health promotion program and promoting its adoption. The HLID
Study is based in the Center on Community Accessibility (CCA) at Oregon Health & Science
University. The mission of CCA is to increase the health and health-related quality of life
of persons with disabilities.
A pilot study conducted by CCA has established the effectiveness of the Healthy Lifestyles
(HL) intervention among a cross-disability population in increasing health behavior
adoption. The specific aim of the HLID Study is to test the efficacy of the HL program
specifically with adults with intellectual disabilities.
The HLID Study uses a randomized control study design. The HL intervention will be
administered to 75 adults and will compare results to those of an additional 75 adults who
receive no intervention. Measurement will include anthropometric assessments to measure
impacts on overweight and obesity, as well as self-report measures of healthy behaviors,
health status, health care utilization, and secondary conditions. Results will be shared
with research participants, presented through professional conferences and newsletters, and
published in peer-reviewed journals with the assistance of community partners.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02791321 -
Fragility Assessment in Adults With ADHD and Mental Retardation
|
N/A | |
Recruiting |
NCT01908400 -
Safety and Efficacy of BMMNCin Patients With Mental Retardation
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02245724 -
Stem Cell Therapy in Mental Retardation
|
Phase 1 | |
Completed |
NCT00156221 -
MR Scanning of Very Young Children With Severe Developmental Disorders
|
N/A | |
Recruiting |
NCT00491478 -
Repetitive Behavior Disorders in People With Severe Mental Retardation
|
Phase 3 | |
Terminated |
NCT02797418 -
"Cognitus & Moi": a New Cognitive Remediation Tool
|
N/A | |
Completed |
NCT00758108 -
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
|
||
Completed |
NCT01430845 -
Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay
|
||
Not yet recruiting |
NCT02214745 -
Demographic Characteristics of Children Suffering From Mental Retardation or Cerebral Palsy in the Israeli Arab Community
|
N/A | |
Active, not recruiting |
NCT00552526 -
Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
|
Phase 4 | |
Completed |
NCT02943304 -
Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero
|
||
Completed |
NCT00491894 -
Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions
|
Phase 3 | |
Completed |
NCT01291238 -
School Intervention With Daily Physical Activity and Healthy Food for Students With an Intellectual Disability.
|
N/A | |
Completed |
NCT01456910 -
Resistance Training Program, Labor Inclusion, Intellectual Disability
|
N/A | |
Completed |
NCT00065273 -
Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay
|
Phase 3 | |
Active, not recruiting |
NCT00065936 -
Self-Injury: Diagnosis and Treatment
|
Phase 3 | |
Completed |
NCT00506259 -
Treatment Strategies for Children With Smith-Magenis Syndrome
|
Phase 1 | |
Not yet recruiting |
NCT05442229 -
A Cross-sectional Study to Evaluate Speech and Language Development in Chinese Children Aged 2-6 Years
|
||
Active, not recruiting |
NCT06370793 -
Ningbo Severe Mental Disorders Cohort
|
||
Completed |
NCT01517048 -
Brain-Derived Neurotrophic Factor in Obesity and Brain Function
|